Professional Documents
Culture Documents
Department of Pharmaceutical Sciences, School of Pharmacy and 5University of Colorado Cancer Center, University of Colorado,
Denver, CO 80045
Abstract
With emerging trends in the incidence of cancer of various organ sites, additional approaches are needed to control human
malignancies. Intervention or prevention of cancer by dietary constituents, a strategy defined as chemoprevention, holds
great promise in our conquest to control cancer, because it can be implemented on a broader population base with less
rich in fruits and vegetables have an overall lower cancer incidence. Based on these encouraging observations, research
efforts from across the globe have focused on identifying, characterizing, and providing scientific basis to the efficacy of
various phytonutrients in an effort to develop effective strategy to control various human malignancies. Cancer induction,
growth, and progression are multi-step events and numerous studies have demonstrated that various dietary agents
interfere with these stages of cancer, thus blocking malignancy. Fruits and vegetables represent untapped reservoir of
various nutritive and nonnutritive phytochemicals with potential cancer chemopreventive activity. Grapes and grape-based
products are one such class of dietary products that have shown cancer chemopreventive potential and are also known to
improve overall human health. This review focuses on recent advancements in cancer chemopreventive and anticancer
efficacy of grape seed extract and other grape-based products. Overall, completed studies from various scientific groups
conclude that both grapes and grape-based products are excellent sources of various anticancer agents and their regular
consumption should thus be beneficial to the general population. J. Nutr. 139: 1806S1812S, 2009.
Introduction
Cancer is a global health problem with high morbidity and
mortality and poses both economic and psychological chal1
Published in a supplement to The Journal of Nutrition. Presented at the conference Grape Health Workshop, held in San Francisco, CA, December 23,
2008. The supplement coordinator for this supplement is John M. Pezzuto,
University of Hawaii at Hilo. Publication costs for this supplement were defrayed
in part by the payment of page charges. This publication must therefore be
hereby marked "advertisement" in accordance with 18 USC section 1734 solely
to indicate this fact. The conference was organized by the National Grape and
Wine Initiative (NGWI) (its contents are solely the responsibility of the authors
and do not necessarily represent the official views of NGWI). Supplement
Coordinator disclosure: John M. Pezzuto serves as Chair of the Grant Review
Committee of the California Table Grape Commission. John M. Pezzuto received
an honorarium to serve as moderator at the Grapes and Health Workshop.
Supplement Guest Editor disclosure: Maria-Luz Fernandez has no relationships
to disclose. The opinions expressed in this publication are those of the authors
and are not attributable to the sponsors or the publisher, Editor, or Editorial Board
of The Journal of Nutrition.
2
Supported by the R01 grants CA91883 from the National Cancer Institute and
AT003623 from the National Center for Complementary and Alternative
Medicine, and the Office of Dietary Supplement, NIH, Bethesda, MD.
3
Author disclosures: M. Kaur, C. Agarwal, and R. Agarwal, no conflicts of
interest.
* To whom correspondence should be addressed. E-mail: rajesh.agarwal@
ucdenver.edu.
1806S
economic burden. Consistent with this, several epidemiological studies have shown that populations that consume diets
6
Abbreviations used: DMBA, 7,12-dimethylbenz[a]anthracene; GSE, grape seed
extract; GSP, polyphenolic fraction from grape seeds; NF-kB, nuclear factor-kB;
PCA, prostate cancer; PIN, prostatic intraepithelial neoplasia, TRAMP, transgenic
adenocarcinoma of the mouse prostate.
1807S
TABLE 1
Organ site
Skin
Colorectal cancer
PCA
DU145 cells
DU145 cells
DU145 tumor xenografts, DU145 cells
Other cancers
Antioxidant
Inhibition of ornithine decarboxylase and myeloperoxidase activities
Antioxidant, YMAPK,2 YNF-kB, Ylipid peroxidation,
Immunosuppression
YCell growth, [apoptosis, [p21 levels
YAberrant crypt foci formation
Antiinflammatory
YAdenosine deaminase activity
Y59-nucleotidase activity
YPI3Kinase, [apoptosis
YProliferation, [apoptosis, Ycholesterol uptake, Y5-lipoxygenase
activity
[Apoptosis
YEGFR-Shc-ERK1/2-ELK1-AP1 pathway
YVEGF,4 [IGFBP-35 in tumors [IGFBP3 in plasma [apoptosis,
YNF-kB, YVEGF secretion
[Apoptosis (anoikis)
Cell cycle arrest
YAromatase activity and expression
Synergistic effects with doxorubicin
Cytotoxic
Antiangiogenic
Antimetastatic effects
Cytotoxic
Reference
23
24,25
26,27,28
29
30
31
32
33
34
35
36
40, 41
44
46
48,49
50
51
53
54
51, 5557
12-O-tetradecanoylphorbol 13-acetate.
Mitogen-activated protein kinases.
Trinitrobenzene sulfonic acid.
4
Vascular endothelial growth factor.
5
Insulin growth factor binding protein-3.
2
3
Supplement
Breast cancer
LNCaP cells
TRAMP model
Aromatase transfected MCF-7 cells
MCF-7, MDA-MB468, MDA-MB231 cells
MCF-7 cells
MCF-7, MDA-MB-231 cells
4T1 Breast cancer cells
A427 lung cancer cells, gastric adenocarcinoma CRL-1739 cells;
A549 and H1299 lung cancer cells; Cal27 and SCC25 oral
squamous cell carcinoma cells; Jurkat cells
Mechanism of action
1809S
TABLE 2
Preclinical and clinical studies showing chemopreventive/anticancer efficacy of whole grape or grape-based products
Chemopreventive
agent
Resveratrol (grape skin,
wine, whole grape)
Piceatannol
Muscadine grape
skin extract
Concord grape extract
1
2
Reference
MCF-7 cells
Autophagy
62
MCF-10F
Two-stage mouse skin cancer model; DMBA-induced
mammary cancer,
Carrageenan-induced inflammation
Human mammary and oral epithelial cells
Dextran sodium sulfate-induced colitis in mice
63
60
64
65
66
67
68
70
71
72
73
and more efforts are needed to identify both the agents and
efficacy in cancer models.
In conclusion, prevention of cancer either by chemopreventive strategies based on naturally occurring agents or simply by
advocating healthy dietary habits should have far reaching
effects on lowering the incidence of cancer and reducing the
socioeconomic burden, as these strategies are most cost effective
and practical in their translational potentials. Additionally,
being natural with increased affordability, they have much
broader access to populations at large. Naturally occurring
phytochemicals have shown promising chemopreventive effects
in various in vitro and preclinical models and in several cases,
their mechanisms of action at the molecular level have been
characterized. However, most of them are in the infancy stage
due to lack of extensive clinical studies yet to be conducted with
these agents. Therefore, more studies are needed in high-risk
populations for cancer of specific organs or sites with standardized GSE preparations to establish the dose regimen and to
determine pharmacologically achievable levels of biologically
active constituents in the plasma/target organ. These studies
would also help establish any toxicity associated with long-term
administration of GSE. Caution is also needed in the use of GSE
and any other given agent in clinical settings until all of their
adverse effects, even as a chemopreventive agent, are evaluated
and established comprehensively. Once such information is
available, it would also be helpful in using these agents as
adjuvants to conventional therapeutic drugs to augment their
therapeutic effect at relatively lower doses, thereby limiting their
toxic side effects to some extent. Based on the evidence from
currently available literature, vegetable- and fruit-based diets/
extracts can be viewed in general as healthy and nutritive with
the additional benefit of being cancer preventive. Together, it can
be concluded that consumption of grapes and/or grape-related
products in diets along with maintaining an active healthy
1810S
Supplement
Literature Cited
1.
36. Tyagi A, Agarwal R, Agarwal C. Grape seed extract inhibits EGFinduced and constitutively active mitogenic signaling but activates JNK
in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. Oncogene. 2003;22:130216.
37. Tang DG, Porter AT. Target to apoptosis: a hopeful weapon for prostate
cancer. Prostate. 1997;32:28493.
38. Lara PN Jr, Twardowski P, Quinn DI. Angiogenesis-targeted therapies in
prostate cancer. Clin Prostate Cancer. 2004;3:16573.
39. Shinkaruk S, Bayle M, Lan G, Deleris G. Vascular endothelial cell
growth factor (VEGF), an emerging target for cancer chemotherapy.
Curr Med Chem Anticancer Agents. 2003;3:95117.
40. Singh RP, Tyagi AK, Dhanalakshmi S, Agarwal R, Agarwal C. Grape
seed extract inhibits advanced human prostate tumor growth and
angiogenesis and upregulates insulin-like growth factor binding protein3. Int J Cancer. 2004;108:73340.
41. Dhanalakshmi S, Agarwal R, Agarwal C. Inhibition of NF-kappaB
pathway in grape seed extract-induced apoptotic death of human
prostate carcinoma DU145 cells. Int J Oncol. 2003;23:7217.
42. Baud V, Karin M. Is NF-kappaB a good target for cancer therapy?
Hopes and pitfalls. Nat Rev Drug Discov. 2009;8:3340.
43. Paule B, Terry S, Kheuang L, Soyeux P, Vacherot F, de la Taille A. The
NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate
cancer: new therapeutic approaches? World J Urol. 2007;25:47789.
44. Kaur M, Agarwal R, Agarwal C. Grape seed extract induces anoikis and
caspase-mediated apoptosis in human prostate carcinoma LNCaP cells:
possible role of ataxia telangiectasia mutated-p53 activation. Mol
Cancer Ther. 2006;5:126574.
45. Gingrich JR, Barrios RJ, Foster BA, Greenberg NM. Pathologic
progression of autochthonous prostate cancer in the TRAMP model.
Prostate Cancer Prostatic Dis. 1999;2:705.
46. Raina K, Singh RP, Agarwal R, Agarwal C. Oral grape seed extract
inhibits prostate tumor growth and progression in TRAMP mice.
Cancer Res. 2007;67:597682.
47. Harada N. Aberrant expression of aromatase in breast cancer tissues.
J Steroid Biochem Mol Biol. 1997;61:17584.
48. Eng ET, Ye J, Williams D, Phung S, Moore RE, Young MK, Gruntmanis
U, Braunstein G, Chen S. Suppression of estrogen biosynthesis by
procyanidin dimers in red wine and grape seeds. Cancer Res. 2003;
63:851622.
49. Kijima I, Phung S, Hur G, Kwok SL, Chen S. Grape seed extract is an
aromatase inhibitor and a suppressor of aromatase expression. Cancer
Res. 2006;66:59607.
50. Sharma G, Tyagi AK, Singh RP, Chan DC, Agarwal R. Synergistic anticancer effects of grape seed extract and conventional cytotoxic agent
doxorubicin against human breast carcinoma cells. Breast Cancer Res
Treat. 2004;85:112.
51. Ye X, Krohn RL, Liu W, Joshi SS, Kuszynski CA, McGinn TR, Bagchi
M, Preuss HG, Stohs SJ, et al. The cytotoxic effects of a novel IH636
grape seed proanthocyanidin extract on cultured human cancer cells.
Mol Cell Biochem. 1999;196:99108.
52. Kim H, Hall P, Smith M, Kirk M, Prasain JK, Barnes S, Grubbs C.
Chemoprevention by grape seed extract and genistein in carcinogeninduced mammary cancer in rats is diet dependent. J Nutr. 2004;134:
S344552.
53. Lu J, Zhang K, Chen S, Wen W. Grape seed extract inhibits VEGF
expression via reducing HIF-1{alpha} protein expression. Carcinogenesis. Epub 2009 Jan 8.
54. Mantena SK, Baliga MS, Katiyar SK. Grape seed proanthocyanidins
induce apoptosis and inhibit metastasis of highly metastatic breast
carcinoma cells. Carcinogenesis. 2006;27:168291.
55. Akhtar S, Meeran SM, Katiyar N, Katiyar SK. Grape seed proanthocyanidins inhibit the growth of human non-small cell lung cancer
xenografts by targeting insulin-like growth factor binding protein-3,
tumor cell proliferation, and angiogenic factors. Clin Cancer Res. 2009;
15:82131.
56. Chatelain K, Phippen S, McCabe J, Teeters CA, OMalley S, Kingsley K.
Cranberry and grape seed extracts inhibit the proliferative phenotype of
oral squamous cell carcinomas. Evid Based Complement Alternat Med.
Epub2008 Jul 23.
57. Gao N, Budhraja A, Cheng S, Yao H, Zhang Z, Shi X. Induction of
apoptosis in human leukemia cells by grape seed extract occurs via
activation of c-Jun NH2-terminal kinase. Clin Cancer Res. 2009;
15:1409.
1811S
1812S
Supplement
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.